These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 12127638

  • 21. Bone mineral density and depot medroxyprogesterone acetate.
    Albertazzi P, Bottazzi M, Steel SA.
    Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
    [Abstract] [Full Text] [Related]

  • 22. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
    Clark MK, Sowers MR, Nichols S, Levy B.
    Fertil Steril; 2004 Dec; 82(6):1580-6. PubMed ID: 15589863
    [Abstract] [Full Text] [Related]

  • 23. [Status of bone mineral density after the long-standing application of contraception Depo-Provera].
    Zeman S, Havlík P, Zemanová J, Němec D.
    Ceska Gynekol; 2013 Jan; 78(1):116-24. PubMed ID: 23607391
    [Abstract] [Full Text] [Related]

  • 24. Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling.
    Shaarawy M, El-Mallah SY, Seoudi S, Hassan M, Mohsen IA.
    Contraception; 2006 Oct; 74(4):297-302. PubMed ID: 16982229
    [Abstract] [Full Text] [Related]

  • 25. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
    Piya-Anant M, Koetsawang S, Patrasupapong N, Dinchuen P, d'Arcangues C, Piaggio G, Pinol A.
    Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
    [Abstract] [Full Text] [Related]

  • 26. Bone mineral density testing, and bisphosphonate and oestrogen prescribing associated with depot medroxyprogesterone acetate utilization-The impact of the boxed warning.
    Eworuke E, Popat V, Moeny DG.
    J Clin Pharm Ther; 2017 Aug; 42(4):483-494. PubMed ID: 28543135
    [Abstract] [Full Text] [Related]

  • 27. Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women.
    Gai L, Jia Y, Zhang M, Gai P, Wang S, Shi H, Yu X, Liu Y.
    Contraception; 2012 Oct; 86(4):332-6. PubMed ID: 22364818
    [Abstract] [Full Text] [Related]

  • 28. Bone mineral density in adolescent and young Thai girls receiving oral contraceptives compared with depot medroxyprogesterone acetate: a cross-sectional study in young Thai women.
    Tharnprisarn W, Taneepanichskul S.
    Contraception; 2002 Aug; 66(2):101-3. PubMed ID: 12204782
    [Abstract] [Full Text] [Related]

  • 29. A prospective, controlled study of the effects of hormonal contraception on bone mineral density.
    Berenson AB, Radecki CM, Grady JJ, Rickert VI, Thomas A.
    Obstet Gynecol; 2001 Oct; 98(4):576-82. PubMed ID: 11576570
    [Abstract] [Full Text] [Related]

  • 30. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.
    Scholes D, LaCroix AZ, Ichikawa LE, Barlow WE, Ott SM.
    Arch Pediatr Adolesc Med; 2005 Feb; 159(2):139-44. PubMed ID: 15699307
    [Abstract] [Full Text] [Related]

  • 31. Trabecular bone in long-term depot-medroxyprogesterone acetate users.
    Virutamasen P, Wangsuphachart S, Reinprayoon D, Kriengsinyot R, Leepipatpaiboon S, Gua C.
    Asia Oceania J Obstet Gynaecol; 1994 Sep; 20(3):269-74. PubMed ID: 7811192
    [Abstract] [Full Text] [Related]

  • 32. Forearm bone density in long-term users of oral combined contraceptives and depot medroxyprogesterone acetate.
    Perrotti M, Bahamondes L, Petta C, Castro S.
    Fertil Steril; 2001 Sep; 76(3):469-73. PubMed ID: 11532466
    [Abstract] [Full Text] [Related]

  • 33. Predictors of higher bone mineral density loss and use of depot medroxyprogesterone acetate.
    Rahman M, Berenson AB.
    Obstet Gynecol; 2010 Jan; 115(1):35-40. PubMed ID: 20027031
    [Abstract] [Full Text] [Related]

  • 34. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
    Harkins GJ, Davis GD, Dettori J, Hibbert ML, Hoyt RA.
    J Reprod Med; 1999 Mar; 44(3):309-12. PubMed ID: 10202754
    [Abstract] [Full Text] [Related]

  • 35. Long-term assessment of forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
    Viola AS, Castro S, Marchi NM, Bahamondes MV, Viola CF, Bahamondes L.
    Contraception; 2011 Aug; 84(2):122-7. PubMed ID: 21757052
    [Abstract] [Full Text] [Related]

  • 36. Forearm bone density in users of Depo-Provera as a contraceptive method.
    Bahamondes L, Perrotti M, Castro S, Faúndes D, Petta C, Bedone A.
    Fertil Steril; 1999 May; 71(5):849-52. PubMed ID: 10231044
    [Abstract] [Full Text] [Related]

  • 37. Effects of hormonal contraception on bone mineral density after 24 months of use.
    Berenson AB, Breitkopf CR, Grady JJ, Rickert VI, Thomas A.
    Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
    [Abstract] [Full Text] [Related]

  • 38. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections.
    Harel Z, Johnson CC, Gold MA, Cromer B, Peterson E, Burkman R, Stager M, Brown R, Bruner A, Coupey S, Hertweck P, Bone H, Wolter K, Nelson A, Marshall S, Bachrach LK.
    Contraception; 2010 Apr; 81(4):281-91. PubMed ID: 20227543
    [Abstract] [Full Text] [Related]

  • 39. Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density.
    Berenson AB, Rahman M, Breitkopf CR, Bi LX.
    Obstet Gynecol; 2008 Oct; 112(4):788-99. PubMed ID: 18827121
    [Abstract] [Full Text] [Related]

  • 40. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z.
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.